YILI(SH:600887) Zheng Quan Ri Bao Wang·2025-11-10 10:13Core Insights - The 8th China International Import Expo was held from November 5 to 10, showcasing Yili Group's commitment to high-quality dairy products and global partnerships [1] - Yili's infant formula products, including Jinlingguan, received significant attention during the expo, highlighting the brand's strength in the market [1][2] Group 1: Event Highlights - Yili Group launched the "2025 China Dairy Quality Creation Conference" and hosted an interactive quality journey at the expo [1] - The event featured a tiered exhibition design, symbolizing Yili's ambition to transition from catching up to surpassing competitors [1] - The successful event demonstrated Yili's strategy of building a "global health ecosystem" through collaboration with international partners [1] Group 2: Product Innovations - Yili's Jinlingguan infant formula incorporates advanced nutritional components, such as 360mg/100g lactoferrin and six times active protein OPN, providing enhanced nutritional protection for infants [2] - The establishment of the Oceania Dairy Industry Base in New Zealand, with a total investment of 3 billion yuan, positions Yili as a leader in integrated infant formula production [2] - Strategic partnerships with prestigious institutions, including Cambridge University and Beijing University, support Yili's research in maternal and infant nutrition [2][3] Group 3: Future Directions - Yili aims to enhance its research, sourcing, and production capabilities to provide diverse nutritional solutions for families [3] - The company is committed to driving high-quality development in China's infant formula industry through continuous innovation [3]